Xcopri 150 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FQJKZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,546
Award facts
- Contract value 100% obligated
- $3,546.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order on September 4, 2025, for XCOPRI 150 mg tablets (30-count) under a firm fixed-price contract valued at $3,546.33. The award was issued by the Defense Logistics Agency, a defense-focused federal procurement entity, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive, non-set-aside award and is a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills critical medical procurement needs for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies. The SPE2DX IDC serves as a global pharmaceutical support vehicle enabling the company to supply brand-name and generic medications, vaccines, specialty drugs, and related medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for XCOPRI, a neurological medication, exemplifies the company's role as a key federal pharmaceutical vendor within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQJKZ?
SPE2DB25FQJKZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FQJKZ worth?
The government has obligated $3,546 on SPE2DB25FQJKZ.
Is contract SPE2DB25FQJKZ an order under another contract?
Yes. SPE2DB25FQJKZ is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJKZ competed?
The extent of competition for SPE2DB25FQJKZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award